Chemotherapy in patients with hepatobiliary cancers and abnormal hepatic function.
Sign Up to like & getrecommendations! Published in 2017 at "Journal of gastrointestinal oncology"
DOI: 10.21037/jgo.2016.09.17
Abstract: Sorafenib and cisplatin plus gemcitabine currently represent first-line treatment standards in advanced hepatocellular carcinoma and biliary cancer, respectively. Conventional cytotoxic agents (monotherapy or combination therapy) have demonstrated activity in the second-line setting or in those… read more here.
Keywords: chemotherapy; patients hepatobiliary; cancers abnormal; chemotherapy patients ... See more keywords